Literature DB >> 29603093

Oxaliplatin Modulates the Characteristics of Voltage-Gated Calcium Channels and Action Potentials in Small Dorsal Root Ganglion Neurons of Rats.

Linda-Isabell Schmitt1, Markus Leo1, Christoph Kleinschnitz1, Tim Hagenacker2.   

Abstract

Oxaliplatin is important for treating colorectal cancer. Although oxaliplatin is highly effective, it has severe side effects, of which neurotoxicity in dorsal root ganglion (DRG) neurons is one of the most common. The key mechanisms of this neurotoxicity are still controversial. However, disturbances of calcium homeostasis in DRG neurons have been suggested to mediate oxaliplatin neurotoxicity. By using whole-cell patch-clamp and current-clamp techniques, as well as immunocytochemical staining, we examined the influence of short- and long-term exposure to oxaliplatin on voltage-gated calcium channels (VGCC) and different VGCC subtypes in small DRG neurons of rats in vitro. Exposure to oxaliplatin reduced VGCC currents (ICa(V)) in a concentration-dependent manner (1-500 μM; 13.8-63.3%). Subtype-specific measurements of VGCCs showed differential effects on ICa(V). While acute treatment with oxaliplatin led to a reduction in ICa(V) for P/Q-, T-, and L-type VGCCs, ICa(V) of N-type VGCCs was not affected. Exposure of DRG neurons to oxaliplatin (10 or 100 μM) for 24 h in vitro significantly increased the ICa(V) current density, with a significant influence on L- and T-type VGCCs. Immunostaining revealed an increase of L- and T-type VGCC protein levels in DRG neurons 24 h after oxaliplatin exposure. This effect was mediated by calcium-calmodulin-protein kinase II (CaMKII). Significant alterations in action potentials (AP) and their characteristics were also observed. While the amplitude increased after oxaliplatin treatment, the rise time and time-to-peak decreased, and these effects were reversed by treatment with pimozide and nimodipine, which suggests that VGCCs are critically involved in oxaliplatin-mediated neurotoxicity.

Entities:  

Keywords:  Chemotherapy; Ion channels; Neuropathic pain; Neurotoxicity; Polyneuropathy; Sensory neurons

Mesh:

Substances:

Year:  2018        PMID: 29603093     DOI: 10.1007/s12035-018-1029-5

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  36 in total

1.  Nomenclature of voltage-gated calcium channels.

Authors:  E A Ertel; K P Campbell; M M Harpold; F Hofmann; Y Mori; E Perez-Reyes; A Schwartz; T P Snutch; T Tanabe; L Birnbaumer; R W Tsien; W A Catterall
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

Review 2.  Oxaliplatin clinical activity: a review.

Authors:  J L Misset; H Bleiberg; W Sutherland; M Bekradda; E Cvitkovic
Journal:  Crit Rev Oncol Hematol       Date:  2000-08       Impact factor: 6.312

3.  Cisplatin-induced activation of the EGF receptor.

Authors:  Moran Benhar; David Engelberg; Alexander Levitzki
Journal:  Oncogene       Date:  2002-12-12       Impact factor: 9.867

Review 4.  Voltage-dependent calcium channels.

Authors:  L Lacinová
Journal:  Gen Physiol Biophys       Date:  2005-06       Impact factor: 1.512

5.  Capsaicin differentially modulates voltage-activated calcium channel currents in dorsal root ganglion neurones of rats.

Authors:  Tim Hagenacker; Frank Splettstoesser; Wolfgang Greffrath; Rolf-Detlef Treede; Dietrich Büsselberg
Journal:  Brain Res       Date:  2005-11-02       Impact factor: 3.252

6.  [Changes in [Ca2+]i and IP3 levels in the process of cisplatin-induced apoptosis of gastric carcinoma].

Authors:  C Xing; J Chen; H Xu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  1999-07

Review 7.  Chemotherapy-induced neuropathy.

Authors:  Anthony J Windebank; Wolfgang Grisold
Journal:  J Peripher Nerv Syst       Date:  2008-03       Impact factor: 3.494

8.  An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections.

Authors:  Nicolas Authier; Jean Pierre Gillet; Joseph Fialip; Alain Eschalier; François Coudore
Journal:  Exp Neurol       Date:  2003-07       Impact factor: 5.330

Review 9.  Abnormal calcium homeostasis in peripheral neuropathies.

Authors:  Paul Fernyhough; Nigel A Calcutt
Journal:  Cell Calcium       Date:  2009-12-24       Impact factor: 6.817

10.  Effect of knockout of α2δ-1 on action potentials in mouse sensory neurons.

Authors:  Wojciech Margas; Laurent Ferron; Manuela Nieto-Rostro; Arnold Schwartz; Annette C Dolphin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-05       Impact factor: 6.237

View more
  10 in total

Review 1.  Modeling chemotherapy induced peripheral neuropathy (CIPN) in vitro: Prospects and limitations.

Authors:  Helmar C Lehmann; Nathan P Staff; Ahmet Hoke
Journal:  Exp Neurol       Date:  2019-12-05       Impact factor: 5.330

2.  [Effect of cinobufagin on transient outward potassium current in dorsal root ganglion cells of rats with cancer-induced bone pain].

Authors:  Shiyu Zhu; Dan Liu; Wei Hu; Hongwei Yang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-09-30

3.  Sexual dimorphism in the contribution of neuroendocrine stress axes to oxaliplatin-induced painful peripheral neuropathy.

Authors:  Larissa Staurengo-Ferrari; Paul G Green; Dionéia Araldi; Luiz F Ferrari; Christine Miaskowski; Jon D Levine
Journal:  Pain       Date:  2021-03-01       Impact factor: 7.926

4.  Examining Sodium and Potassium Channel Conductances Involved in Hyperexcitability of Chemotherapy-Induced Peripheral Neuropathy: A Mathematical and Cell Culture-Based Study.

Authors:  Parul Verma; Muriel Eaton; Achim Kienle; Dietrich Flockerzi; Yang Yang; Doraiswami Ramkrishna
Journal:  Front Comput Neurosci       Date:  2020-10-15       Impact factor: 2.380

Review 5.  Application Potential of Plant-Derived Medicines in Prevention and Treatment of Platinum-Induced Peripheral Neurotoxicity.

Authors:  Xiaowei Xu; Liqun Jia; Xiaoran Ma; Huayao Li; Changgang Sun
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

Review 6.  Targeting strategies for oxaliplatin-induced peripheral neuropathy: clinical syndrome, molecular basis, and drug development.

Authors:  Yang Yang; Bing Zhao; Xuejiao Gao; Jinbing Sun; Juan Ye; Jun Li; Peng Cao
Journal:  J Exp Clin Cancer Res       Date:  2021-10-22

7.  Pretreatment with Zonisamide Mitigates Oxaliplatin-Induced Toxicity in Rat DRG Neurons and DRG Neuron-Schwann Cell Co-Cultures.

Authors:  Shizuka Takaku; Kazunori Sango
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

Review 8.  Repurposing antipsychotics of the diphenylbutylpiperidine class for cancer therapy.

Authors:  Vikram Shaw; Suyash Srivastava; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2019-10-13       Impact factor: 15.707

Review 9.  Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy.

Authors:  Kinga Sałat
Journal:  Pharmacol Rep       Date:  2020-05-11       Impact factor: 3.024

10.  Platinum-Based Drugs Cause Mitochondrial Dysfunction in Cultured Dorsal Root Ganglion Neurons.

Authors:  Markus Leo; Linda-Isabell Schmitt; Patricia Küsterarent; Andrea Kutritz; Tienush Rassaf; Christoph Kleinschnitz; Ulrike B Hendgen-Cotta; Tim Hagenacker
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.